19 articles tagged with "pharmaceuticals"
Steve Ubl, the CEO of PhRMA, will resign at the end of the year, marking a notable shift in the pharmaceutical lobbying arena after leading for more than ten years.
The agency's recent announcement highlights growing public concern over health risks associated with these chemicals.
The taxes are part of the president's push to rein in the pharmaceutical industry and bring manufacturing to the U.S.
Strategic angle: The Trump administration is in talks with smaller pharmaceutical companies to establish new drug-pricing agreements.
Strategic angle: The company showcases robust growth prospects driven by its diverse therapeutic offerings.
Strategic angle: The organization criticized Gilead Sciences after months of negotiations for a limited supply of lenacapavir.
Strategic angle: The White House shares legislative text on drug pricing with major pharmaceutical companies.
Strategic angle: Exploring the dynamics of proteins may unlock new possibilities in pharmaceutical development.
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but it could eventually — affecting prices.
Strategic angle: A new bill aims to mandate drugmakers and patient groups to reveal their connections to disease awareness initiatives.
Strategic angle: Johnson & Johnson's new daily psoriasis pill offers benefits comparable to injectable treatments, potentially disrupting a multibillion-dollar market.
Strategic angle: The White House intensifies pressure on Congress for drug pricing legislation.
Strategic angle: Families report financial and treatment struggles after GSK's price increases on asthma inhalers.
An experimental obesity pill from Structure Therapeutics helped patients lose significant weight in a mid-stage trial, with a Phase 3 study in the works.
Farmers in water-scarce areas can safely use treated wastewater for irrigation, as certain crops can absorb and store pharmaceutical byproducts.
Strategic angle: Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals.
Strategic angle: Exploring strategies for drug manufacturers and distributors to enhance supply chain resilience amidst tariffs and disruptions.
Strategic angle: Researchers discover new functions of the cereblon protein that could enhance cancer drug efficacy.
Servier's acquisition of Day One Biopharmaceuticals for $2.5 billion could reshape its position in the pediatric oncology market, but risks remain.